These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 26714359)
1. Dry-heat Depyrogenation Ovens for Pharmaceutical Compounding Facilities. Weller T; Kragseth R; Dullinger R; Illum H; Perry A Int J Pharm Compd; 2015; 19(3):182-92. PubMed ID: 26714359 [TBL] [Abstract][Full Text] [Related]
2. Depyrogenation options for the compounding cleanroom. Weller T; Bell J; Dullinger R; Allen V; Anthenat B Int J Pharm Compd; 2014; 18(6):446-54. PubMed ID: 25906620 [TBL] [Abstract][Full Text] [Related]
3. Quality Assurance and Quality Control, Part 2. Akers MJ Int J Pharm Compd; 2015; 19(3):215-21. PubMed ID: 26714362 [TBL] [Abstract][Full Text] [Related]
4. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding. Hyde TD Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341 [TBL] [Abstract][Full Text] [Related]
6. Basics of sterile compounding: bubble point testing. Thoma L Int J Pharm Compd; 2014; 18(1):54-7. PubMed ID: 24881342 [TBL] [Abstract][Full Text] [Related]
7. Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations. Trissel LA; Gentempo JA; Saenz LM; Woodard MY; Angeles CH Am J Health Syst Pharm; 2007 Apr; 64(8):837-41. PubMed ID: 17420200 [TBL] [Abstract][Full Text] [Related]
8. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies. Kastango ES JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322 [TBL] [Abstract][Full Text] [Related]
10. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals. Hung JC J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115 [No Abstract] [Full Text] [Related]
11. Automated endotoxin testing program for high-risk-level compounded sterile preparations at an institutional compounding pharmacy. Cooper JF; Latta KS; Smith D Am J Health Syst Pharm; 2010 Feb; 67(4):280-6. PubMed ID: 20133532 [TBL] [Abstract][Full Text] [Related]
12. U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies. Yoch D Int J Pharm Compd; 2017; 21(2):95-102. PubMed ID: 28346203 [TBL] [Abstract][Full Text] [Related]
13. [Bacteriological quality of air in a ward for sterile pharmaceutical preparations]. Caorsi P B; Sakurada Z A; Ulloa F MT; Pezzani V M; Latorre O P Rev Chilena Infectol; 2011 Feb; 28(1):14-8. PubMed ID: 21526280 [TBL] [Abstract][Full Text] [Related]
15. Does your pharmacy have a compounding isolator? LaBella CJ Am J Health Syst Pharm; 2007 Apr; 64(8):855-8. PubMed ID: 17420203 [No Abstract] [Full Text] [Related]
17. Choosing a Vial Processing Line for Aseptic Compounding: Part 1. Noorian S; Vahedi N Int J Pharm Compd; 2016; 20(4):283-292. PubMed ID: 28333673 [TBL] [Abstract][Full Text] [Related]
18. End-preparation assessments and tests for compounded sterile preparations. McElhiney LF Int J Pharm Compd; 2013; 17(4):307-11. PubMed ID: 24261146 [TBL] [Abstract][Full Text] [Related]
19. USP publishes enforceable chapter on sterile compounding. Thompson CA Am J Health Syst Pharm; 2003 Sep; 60(18):1814, 1817-8, 1822. PubMed ID: 14521028 [No Abstract] [Full Text] [Related]
20. Potential for airborne contamination in turbulent- and unidirectional-airflow compounding aseptic isolators. Peters GF; McKeon MR; Weiss WT Am J Health Syst Pharm; 2007 Mar; 64(6):622-31. PubMed ID: 17353571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]